Tilray Brands Posts Flat Revenue In Q1 2023

Tilray Brands (TSX: TLRY) this morning posted its first quarter financial results, with revenues staying flat on a quarter over quarter basis. The company meanwhile maintained that it retained the top spot within Canadian markets in terms of market share, with an 8.5% stake in the market.

Revenue for the quarter came in at $153.2 million, versus $153.3 million in the prior quarter, and $168.0 million in the year ago period. Of the revenue recorded, cannabis amounted to 38% of revenue at $61.6 million, while distribution revenue came in at $70.6 million, or 42%, beverage alcohol came in at $20.7 million, or 12%, and the wellness division came in at $13.7 million, or 8%. Gross profit meanwhile amounted to $48.6 million.

“Tilray Brands’ top and bottom-line results during the first quarter reflect successful realignment of the business to maximize revenue and market share gains across core business segments and geographies. Most notably, we are now the leader in net cannabis revenue worldwide [in federally legal markets], highlighted by medical cannabis leadership globally and adult-use cannabis market share primacy in Canada. These achievements affirm that, amid market disruption and macroeconomic challenges, we have leveraged our scale, marketing acumen and CPG expertise to deliver strong — and sustainable — top line growth,” commented Irwin Simon, CEO of Tilray.

While gross profit improved over the negative $6.7 million recorded in the fourth quarter, Tilray has yet to effectively grab control of its costs, with operating expenses totaling $69.8 million for the three month period, resulting in an operating loss of $21.2 million for the quarter. This was largely driven by general and administrative expenses of $40.5 million and amortization expenses of $24.4 million, and offset by transaction income of $12.8 million.

READ: President Biden Begins Process Of Reviewing Legality Of Cannabis At Federal Level

Overall, Tilray reported a net loss of $65.8 million, or $0.13 per share. Adjusted EBITDA was reported at $13.5 million. The company also confirmed guidance of $70 to $80 million in positive adjusted EBITDA for the fiscal year, and to be free cash flow positive in its operating business units this year. Free cash flow for the current quarter meanwhile was negative $47.8 million.

In terms of its balance sheet, the company saw its cash position improve to $490.6 million, while total assets overall grew to $910.9 million from $803.5 million. Total current liabilities meanwhile declined from $280.3 million to $273.3 million.

Tilray Brands last traded at $5.37 on the TSX.


Information for this briefing was found via Sedar and the companies mentioned. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

This Gold Story Starts With Cash Flow | Gordon Robb – ESGold

Silverco Cusi Mine PEA: Bigger Isn’t Always Better

Fixing Heart Disease Tied to Sudden Death in Young People | David Elsley – Cardiol Therapeutics

Recommended

Two Vessels Attacked Near Strait of Hormuz Within Hours as IRGC Escalates Maritime Campaign

Cambria Drills 17.95 g/t Gold Over 22 Metres At Premier Mine

Related News

Tilray Records US$48.17 in Third Quarter Revenues

Tilray Inc (NASDAQ: TLRY) reported third quarter financial results after the bell today, posting net...

Tuesday, November 12, 2019, 05:33:16 PM

Tilray Selected To Supply Medical Cannabis For French Experimental Program

Tilray Inc (NASDAQ: TLRY) has expanded its international operations to now include France. The company...

Tuesday, January 26, 2021, 07:55:19 AM

Cantor Releases Industry Report For Cannabis, Aphria Remains Top Pick

Recently, Cantor Fitzgerald released their monthly review of Hifyre data for the four weeks ending...

Sunday, October 4, 2020, 01:57:00 PM

BofA Terminates Coverage On Tilray, Aurora Cannabis

On November 18th, Bank of America terminated coverage on Tilray Inc (TSX: TLRY) and Aurora...

Friday, November 19, 2021, 11:47:00 AM

Aphria, Tilray Granted Regulatory Clearance Under Competition Act For Combination

Aphria Inc (TSX: APHA) (NASDAQ: APHA) this evening reported that the transaction with that of...

Tuesday, February 23, 2021, 04:27:22 PM